Scarica l'app Stockscreener
415.34
1.35%
-5.70
Dopo l'orario di chiusura:
416.00
0.66
+0.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
United Therapeutics Corp Borsa (UTHR) Ultime notizie
United Therapeutics’ Promising Study on Inhaled Treprostinil for Lung Disease - TipRanks
United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis - TipRanks
United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients - TipRanks
United Therapeutics’ DeciPHer-ILD Study: A Closer Look at PH-ILD Patient Registry - TipRanks
United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension - TipRanks
United Therapeutics Advances Ralinepag Study for PAH Treatment - TipRanks
Will United Therapeutics Corporation stock benefit from upcoming earnings reports2025 Risk Factors & Reliable Breakout Forecasts - newser.com
What margin trends mean for United Therapeutics Corporation stockMarket Growth Review & Consistent Profit Trading Strategies - newser.com
Nepsis Liquidates $14 Million CyberArk Software (NASDAQ: CYBR) Position: Did the Stock Soar Too High, Too Fast? - The Motley Fool
Published on: 2025-10-26 13:21:57 - newser.com
Will United Therapeutics Corporation benefit from macro trendsMarket Weekly Review & Precise Swing Trade Alerts - newser.com
How United Therapeutics Corporation (UTH) stock benefits from digital adoptionJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
What data driven models say about United Therapeutics Corporation’s future2025 Sector Review & Fast Moving Stock Watchlists - newser.com
Risk adjusted return profile for United Therapeutics Corporation analyzedJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
What makes United Therapeutics Corporation stock attractive to growth fundsTrade Risk Assessment & Precise Trade Entry Recommendations - newser.com
United Therapeutics Executives Sell Shares - TradingView
United Therapeutics EVP & General Counsel Sells 11,000 Shares - TradingView
Why United Therapeutics Corporation (UTH) stock gets analyst attention2025 Buyback Activity & Reliable Momentum Entry Alerts - newser.com
United Therapeutics Corporation (UTHR) Stock forecasts - Yahoo
Will United Therapeutics Corporation (UTH) stock attract long term capital inflowsJuly 2025 Setups & Weekly High Potential Alerts - Trung tâm Dự báo KTTV quốc gia
Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case - Insider Monkey
United Therapeutics CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView
PH-ILD hospitalization data on inhaled treprostinil — United Therapeutics at CHEST 2025 - Stock Titan
Callan Family Office LLC Increases Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (FRA:UTH) Gross-Profit-to-Asset % : 35.18% (As of Jun. 2025) - GuruFocus
UTHR (United Therapeutics) Cyclically Adjusted PB Ratio : 4.79 (As of Oct. 12, 2025) - GuruFocus
Inspire Investing LLC Trims Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
UTHR (United Therapeutics) 5-Year RORE % : 17.31% (As of Jun. 2025) - GuruFocus
UTHR (United Therapeutics) Revenue per Share : $63.53 (TTM As of Jun. 2025) - GuruFocus
Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics Corp. Hits New 52-Week High of $455.26 - Markets Mojo
United Therapeutics Corp. Hits New 52-Week High of $459.48 - Markets Mojo
United Therapeutics Corp. Hits New 52-Week High of $455.00 - Markets Mojo
United Therapeutics (NASDAQ:UTHR) Sets New 52-Week HighHere's What Happened - MarketBeat
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat
QRG Capital Management Inc. Raises Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
Is There Still an Opportunity in United Therapeutics After Its 25.8% Year to Date Surge? - simplywall.st
Polaris Capital Management LLC Reduces Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
Hilltop National Bank Takes $341,000 Position in United Therapeutics Corporation $UTHR - MarketBeat
What Catalysts Are Reshaping the Narrative for United Therapeutics This Year? - Yahoo Finance
A Look at United Therapeutics (UTHR) Valuation as Tyvaso Shows Breakthrough Results in Late-Stage IPF Trial - simplywall.st
How Positive TETON-2 Results for Tyvaso Have Changed United Therapeutics' (UTHR) Investment Story - simplywall.st
News impact scoring models applied to United Therapeutics CorporationPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com
Robeco Institutional Asset Management B.V. Boosts Stake in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics stock hits all-time high at 442.02 USD - Investing.com
United Therapeutics stock hits all-time high at 442.02 USD By Investing.com - Investing.com South Africa
United Therapeutics rides Tyvaso optimism as IPF trial gains momentum - S&P Global
TD Cowen maintains Buy rating on United Therapeutics stock, citing IPF opportunity - Investing.com
Jefferies reiterates Buy rating on United Therapeutics stock amid patent case - Investing.com
UBS maintains United Therapeutics stock Buy rating amid patent litigation By Investing.com - Investing.com Canada
United Therapeutics COO sells $9.49m in UTHR stock By Investing.com - Investing.com South Africa
United Therapeutics COO sells $9.49m in UTHR stock - Investing.com India
0.87%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):